90 related articles for article (PubMed ID: 14636832)
1. Differential inhibition of receptor activation by two mouse monoclonal antibodies specific for the human leukotriene B4 receptor, BLT1.
Sabirsh A; Pettersson A; Boketoft A; Kotarsky K; Owman C
Int Immunopharmacol; 2003 Dec; 3(13-14):1829-39. PubMed ID: 14636832
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric mapping of the leukotriene B4 receptor, BLT1, in human bone marrow and peripheral blood using specific monoclonal antibodies.
Pettersson A; Richter J; Owman C
Int Immunopharmacol; 2003 Oct; 3(10-11):1467-75. PubMed ID: 12946443
[TBL] [Abstract][Full Text] [Related]
3. First-generation monoclonal antibodies identifying the human leukotriene B(4) receptor-1.
Pettersson A; Boketoft A; Sabirsh A; Nilsson NE; Kotarsky K; Olde B; Owman C
Biochem Biophys Res Commun; 2000 Dec; 279(2):520-5. PubMed ID: 11118319
[TBL] [Abstract][Full Text] [Related]
4. Recognition of human polymorphonuclear leukocyte receptors for leukotriene B4 by rabbit anti-idiotypic antibodies to a mouse monoclonal antileukotriene B4.
Gifford LA; Chernov-Rogan T; Harvey JP; Koo CH; Goldman DW; Goetzl EJ
J Immunol; 1987 Feb; 138(4):1184-9. PubMed ID: 3027172
[TBL] [Abstract][Full Text] [Related]
5. cDNA cloning and characterization of guinea-pig leukotriene B4 receptor.
Masuda K; Yokomizo T; Izumi T; Shimizu T
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):79-85. PubMed ID: 10432303
[TBL] [Abstract][Full Text] [Related]
6. Agonist-induced internalization of leukotriene B(4) receptor 1 requires G-protein-coupled receptor kinase 2 but not arrestins.
Chen Z; Gaudreau R; Le Gouill C; Rola-Pleszczynski M; Stanková J
Mol Pharmacol; 2004 Sep; 66(3):377-86. PubMed ID: 15322228
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-dependent vascular responses induced by leukotriene B4.
Bäck M; Sakata K; Qiu H; Haeggström JZ; Dahlén SE
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):209-12. PubMed ID: 17481557
[TBL] [Abstract][Full Text] [Related]
8. Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors.
McHugh D; McMaster RS; Pertwee RG; Roy S; Mahadevan A; Razdan RK; Ross RA
J Pharmacol Exp Ther; 2006 Feb; 316(2):955-65. PubMed ID: 16207832
[TBL] [Abstract][Full Text] [Related]
9. Residues from transmembrane helices 3 and 5 participate in leukotriene B4 binding to BLT1.
Sabirsh A; Bywater RP; Bristulf J; Owman C; Haeggström JZ
Biochemistry; 2006 May; 45(18):5733-44. PubMed ID: 16669617
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive effect of leukotriene B(4) receptor antagonist in vitro.
Morita H; Takeda K; Yagita H; Okumura K
Biochem Biophys Res Commun; 1999 Oct; 264(2):321-6. PubMed ID: 10529362
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues.
Goodarzi K; Goodarzi M; Tager AM; Luster AD; von Andrian UH
Nat Immunol; 2003 Oct; 4(10):965-73. PubMed ID: 12949533
[TBL] [Abstract][Full Text] [Related]
12. Subcellular localization of leukotriene receptors in human endothelial cells.
Johansson AS; Haeggström JZ; Hultenby K; Palmblad J
Exp Cell Res; 2010 Oct; 316(17):2790-6. PubMed ID: 20688055
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of rat leukotriene B(4) receptor.
Toda A; Yokomizo T; Masuda K; Nakao A; Izumi T; Shimizu T
Biochem Biophys Res Commun; 1999 Sep; 262(3):806-12. PubMed ID: 10471406
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1.
Goodnow RA; Hicks A; Sidduri A; Kowalczyk A; Dominique R; Qiao Q; Lou JP; Gillespie P; Fotouhi N; Tilley J; Cohen N; Choudhry S; Cavallo G; Tannu SA; Ventre JD; Lavelle D; Tare NS; Oh H; Lamb M; Kurylko G; Hamid R; Wright MB; Pamidimukkala A; Egan T; Gubler U; Hoffman AF; Wei X; Li YL; O'Neil J; Marcano R; Pozzani K; Molinaro T; Santiago J; Singer L; Hargaden M; Moore D; Catala AR; Chao LC; Hermann G; Venkat R; Mancebo H; Renzetti LM
J Med Chem; 2010 May; 53(9):3502-16. PubMed ID: 20380377
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.
Birke FW; Meade CJ; Anderskewitz R; Speck GA; Jennewein HM
J Pharmacol Exp Ther; 2001 Apr; 297(1):458-66. PubMed ID: 11259574
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene B4 is the functional ligand binding to and activating the cloned chemoattractant receptor, CMKRL1.
Owman C; Sabirsh A; Boketoft A; Olde B
Biochem Biophys Res Commun; 1997 Nov; 240(1):162-6. PubMed ID: 9367903
[TBL] [Abstract][Full Text] [Related]
17. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation.
Iikura M; Suzukawa M; Yamaguchi M; Sekiya T; Komiya A; Yoshimura-Uchiyama C; Nagase H; Matsushima K; Yamamoto K; Hirai K
J Allergy Clin Immunol; 2005 Sep; 116(3):578-85. PubMed ID: 16159627
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene B4 receptor (BLT-1) modulates neutrophil influx into the peritoneum but not the lung and liver during surgically induced bacterial peritonitis in mice.
Scott MJ; Cheadle WG; Hoth JJ; Peyton JC; Subbarao K; Shao WH; Haribabu B
Clin Diagn Lab Immunol; 2004 Sep; 11(5):936-41. PubMed ID: 15358656
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2-dependent pathways are essential for CD8+ T cell-mediated airway hyperresponsiveness and inflammation.
Ohnishi H; Takeda K; Domenico J; Lucas JJ; Miyahara N; Swasey CH; Dakhama A; Gelfand EW
J Allergy Clin Immunol; 2009 Jan; 123(1):249-57. PubMed ID: 19130938
[TBL] [Abstract][Full Text] [Related]
20. House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1.
Svensson L; Redvall E; Björn C; Karlsson J; Bergin AM; Rabiet MJ; Dahlgren C; Wennerås C
Eur J Immunol; 2007 Jul; 37(7):1966-77. PubMed ID: 17559171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
